【24h】

The use of drug monotherapy in psychiatric inpatient treatment.

机译:在精神科住院治疗中使用药物单一疗法。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Monotherapy has always been the goal in psychiatric drug treatment, but it does not seem to be very common in everyday practice. METHOD: The available literature on the frequency of monotherapy or polytherapy with psychotropic agents in psychiatric inpatient treatment is reviewed. FINDINGS: Taken all together (28 studies on 42 treatment facilities), the mean number of psychotropics prescribed was 2.47, the rate of monotherapy was 36.2% and 37.9% of inpatients received > or = 3 different drugs. Comparing the last three decades, a significant decline of the rate of monotherapy was found, topping at 47.8% in the 70s and falling to 19.6% in the 90s. The mean number of psychotropic drugs prescribed rose from 2.2 to 2.9 and the number of patients receiving > or = 3 psychotropics rose from 27.5 to 49.7%. CONCLUSION: Though it is still mandatory to avoid unsound polypharmacy, we must assume that the occasions for polypharmacy are increasing. New psychotropic drugs, increasing comorbidity and augmentation strategies may be incentives for polydrug use. Since in most countries the number of psychiatric beds declines, inpatient treatment has to deal with the most severe, often treatment-resistant patients requiring special therapies.
机译:目的:单一疗法一直是精神药物治疗的目标,但在日常实践中似乎并不普遍。方法:综述了有关精神病住院治疗中单一或联合精神药物治疗频率的文献。结果:总共(在42个治疗设施上进行了28项研究),开出的平均精神药物处方数为2.47,单药治疗的比率分别为36.2%和37.9%的住院患者≥3种药物。与最近的三十年相比,发现单药治疗的比率显着下降,在70年代达到47.8%,在90年代下降到19.6%。开处方的精神药物的平均数量从2.2上升到2.9,接受>或= 3精神药物的患者数量从27.5上升到49.7%。结论:尽管仍然有必要避免不健全的多药店,但我们必须假设多药店的机会在增加。新的精神药物,合并症和增加策略可能是多药使用的诱因。由于在大多数国家,精神科病床数量减少,因此住院治疗必须应对最严重的,通常对治疗有抵抗力的需要特殊治疗的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号